Patents by Inventor Oliver Krämer

Oliver Krämer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8598157
    Abstract: 5-alkynyl-pyridine of general formula (I) their use as inhibitors of the activity of PI3Kalpha, pharmaceutical compositions containing them, and their use as a medicaments for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. The groups R1 to R6 and n have the meanings given in the claims and in the specification.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: December 3, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Tobias Wunberg, Oliver Kraemer, Lars van der Veer
  • Publication number: 20130281429
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.
    Type: Application
    Filed: March 26, 2013
    Publication date: October 24, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Stephan Karl ZAHN, Guido BOEHMELT, Andreas MANTOULIDIS, Ulrich REISER, Matthias TREU, Ulrich GUERTLER, Andreas SCHOOP, Flavio SOLCA, Ulrike TONTSCH-GRUNT, Ralph BRUECKNER, Charlotte REITHER, Lars HERFURTH, Oliver KRAEMER, Heinz STADTMUELLER, Harald ENGELHARDT
  • Publication number: 20130274981
    Abstract: A method is provided for operating a hybrid vehicle equipped with an internal-combustion engine and an electric drive for generating vehicle propulsion. The vehicle selectively is driven in a first operating mode exclusively by the electric drive or in a second operating mode is driven by the internal combustion engine and by the electric drive, or in a third operating mode is driven exclusively by the internal combustion engine. In the first operating mode, the driver predefines a desired driving torque via a selection element. The first operating mode is maintained even if the desired driving torque is greater than a maximal driving torque that can presently be supplied by the electric motor.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 17, 2013
    Inventor: Oliver KRAEMER
  • Publication number: 20130249847
    Abstract: An operating device for a household appliance includes an electronic display panel, and an operating element that is displaceable relative to the display panel to set operating conditions of the household appliance. The operating element has a region which is disposed within an area of the display panel.
    Type: Application
    Filed: December 12, 2011
    Publication date: September 26, 2013
    Applicant: BSH BOSCH UND SIEMENS HAUSGERÄTE GmbH
    Inventors: Ulrich Goss, Oliver Kraemer, Robert Sachon
  • Patent number: 8466162
    Abstract: 5-alkynyl-pyridine of general formula (I) which are inhibitors of the activity of PI3K alpha, and their use in the treatment of diseases characterized by excessive or abnormal cell proliferation, such as cancer.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: June 18, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Tobias Wunberg, Oliver Kraemer, Lars Van Der Veen
  • Publication number: 20130023519
    Abstract: 5-alkynyl-pyridine of general formula (I) their use as inhibitors of the activity of PI3Kalpha, pharmaceutical compositions containing them, and their use as a medicaments for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. The groups R1 to R6 and n have the meanings given in the claims and in the specification.
    Type: Application
    Filed: January 24, 2012
    Publication date: January 24, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tobias WUNBERG, Oliver KRAEMER, Lars van der VEEN
  • Publication number: 20130023533
    Abstract: 5-alkynyl-pyridine of general formula (I) which are inhibitors of the activity of PI3K alpha, and their use in the treatment of diseases characterized by excessive or abnormal cell proliferation, such as cancer.
    Type: Application
    Filed: January 24, 2012
    Publication date: January 24, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tobias WUNBERG, Oliver KRAEMER, Lars van der VEEN
  • Patent number: 8304556
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: November 6, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Darryl McConnell, Maria Impagnatiello, Dirk Kessler, Oliver Kraemer, Siegfried Schneider, Lars Van Der Veen, Ulrike Weyer-Czernilofsky, Tobias Wunberg
  • Publication number: 20120270859
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a pharmaceutical composition having the above-mentioned properties.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 25, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Matthias TREU, Ulrich GUERTLER, Thomas KARNER, Oliver KRAEMER, Jens Juergen QUANT, Stephan Karl ZAHN
  • Publication number: 20120255267
    Abstract: A filter unit for an extractor hood includes at least one filter element, and at least one protection plate which is arranged in a flow direction upstream of the filter element. The protection plate is made of at least two layers and can have a thickness in a range of 0.5 mm to 10 mm.
    Type: Application
    Filed: April 10, 2012
    Publication date: October 11, 2012
    Applicant: BSH BOSCH UND SIEMENS HAUSGERATE GMBH
    Inventors: Julia Ehrensberger, Ralf Grobleben, Sándor Klunker, Thomas Kotlinski, Oliver Kraemer, Daniel Metz, Christoph Ortmann, Udo Reiff, Volkmar Uebele
  • Patent number: 8243664
    Abstract: The present invention relates to the field of multi-path wireless communication. The present invention provides a system for assisting in providing a wireless communication link between a first communication device and a second communication device based on a plurality of communication paths comprising a history manager for providing, based on a recorded history of communication path states, a proposal for one or more communication paths based on which the communication link can be provided. The present invention further provides a corresponding method and a communication system and a communication device comprising the system of the present invention. Based on the proposal provided by the present invention, path switching can be performed more effectively, less and shorter interruptions of the communication link can be obtained and an enhanced transmission quality can be provided for multi-path wireless communication systems.
    Type: Grant
    Filed: May 15, 2008
    Date of Patent: August 14, 2012
    Assignee: Sony Deutschland GmbH
    Inventors: Volker Wullich, Oliver Kraemer
  • Patent number: 8207179
    Abstract: The present invention encompasses compounds of general Formula (1) wherein R2, R3, Q, W, X, Y and Z are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: June 26, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Harald Engelhardt, Bodo Betzemeier, Guido Boehmelt, Ulrich Guertler, Thomas Karner, Oliver Kraemer, Daniel Kuhn, Jens Juergen Quant, Ulrich Reiser, Otmar Schaaf, Flavio Solca, Heinz Stadtmueller, Ulrike Tontsch-Grunt, Matthias Treu, Stephan Karl Zahn
  • Patent number: 8203001
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1, M1, L1 and Q are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: June 19, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Ulrich Reiser, Peter Ettmayer, Oliver Kraemer, Peter Sennhenn, Walter Spevak
  • Publication number: 20120108567
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 3, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Darryl McCONNELL, Maria IMPAGNATIELLO, Dirk KESSLER, Oliver KRAEMER, Siegfried SCHNEIDER, Lars VAN DER VEEN, Ulrike WEYER-CZERNILOFSKY, Tobias WUNBERG
  • Publication number: 20110281838
    Abstract: The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: July 28, 2009
    Publication date: November 17, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tobias Wunberg, Ralph Brueckner, Dirk Kessler, Oliver Kraemer, Darryl McConnell, Siegfried Schneider, Lars van der Veen
  • Publication number: 20110251174
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.
    Type: Application
    Filed: June 14, 2011
    Publication date: October 13, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Stephan Karl ZAHN, Guido BOEHMELT, Andreas MANTOULIDIS, Ulrich REISER, Matthias TREU, Ulrich GUERTLER, Andreas SCHOOP, Flavio SOLCA, Ulrike TONTSCH-GRUNT, Ralph BRUECKNER, Charlotte REITHER, Lars HERFURTH, Oliver KRAEMER, Heinz STADTMUELLER, Harald ENGELHARDT
  • Patent number: 8027282
    Abstract: A heterogeneous wireless network topology suited for low-power, short-range and ubiquitous ad-hoc communication. The network topology integrates different wireless transmission technologies, in particular to a wireless sensor network including different node types and communication technologies. The network is highly heterogeneous and can be operated according to the master-slave principle. The nodes can have different wireless communication means tailored to their individual role in the network and other constraints, thus allowing different communication patterns.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: September 27, 2011
    Assignee: Sony Deutschland GmbH
    Inventors: Ralf Boehnke, Juan Nogueira-Nine, Volker Wullich, Oliver Kraemer, Ingo Ruhm, Zhaocheng Wang, Jochen Rebmann
  • Patent number: 8014828
    Abstract: The present invention relates to a transmitting device (1) for transmitting signals in a wireless communication system, wherein said signals are transmitted in consecutive frames (23a, 23b, 23c), each frame comprising a beacon (BSF) and data frames (DF), said transmitting device (1) comprising a first set of narrow beam antennas (2a, 2b, 2c), each narrow beam antenna (2a, 2b, 2c) having a different beaming direction corresponding to one of a number of different transmission paths (P0, P1, P2) from said transmitting device (1) to a receiving device, and a first control means (5) adapted to control the transmission of said frames (23a, 23b, 23c), whereby the data frames (DF) of respectively two consecutive frames (23a, 23b, 23c) are transmitted via different narrow beam antennas (2a, 2b, 2c).
    Type: Grant
    Filed: February 6, 2008
    Date of Patent: September 6, 2011
    Assignee: Sony Deutschland GmbH
    Inventors: Oliver Kraemer, Volker Wullich
  • Publication number: 20110118208
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: March 13, 2009
    Publication date: May 19, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Darryl Mcconnell, Maria Impagnatiello, Dirk Kessler, Oliver Kraemer, Siegfried Schneider, Lars Van Der Veen, Ulrike Weyer-Czernilofsky, Tobias Wunberg
  • Publication number: 20100222331
    Abstract: The present invention encompasses compounds of general Formula (1) wherein R2, R3, Q, W, X, Y and Z are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: June 9, 2008
    Publication date: September 2, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Harald Engelhardt, Bodo Betzemeier, Guido Boehmelt, Ulrich Guertler, Thomas Karner, Oliver Kraemer, Daniel Kuhn, Jens Juergen Quant, Ulrich Reiser, Otmar Schaaf, Flavio Solca, Heinz Stadtmueller, Ulrike Tontsch-Grunt, Matthias Treu, Stephan Karl Zahn